Shenzhen-Hong Kong Cell Valley (Shenzhen) Medical Technology Co., Ltd. is a joint venture between Hong Kong Cell Valley (80% stake) and Shenzhen Cell Valley (20% stake). With a registered capital of RMB 100 million, the company is located in Phase II of the Qianhai Shenzhen-Hong Kong Youth Dream Factory in Nanshan District, Shenzhen, covering an area of over 1,100 square meters. The company specializes in the development of new cell and gene therapy (CGT) drugs, high-end medical services, precision medical testing, and the anti-aging and health care industries.
As one of the key investment projects for the Qianhai Free Trade Zone’s 10th anniversary, the company leverages Shenzhen Cell Valley’s strong R&D and technological foundation and Hong Kong Cell Valley’s abundant capital and international resources to advance the development of cell therapy drugs, personalized medical care, and health management services. Its business covers areas such as oncology, autoimmune diseases, degenerative geriatric diseases, and cancer prevention.
Based in Shenzhen, Shenzhen-Hong Kong Cell Valley will radiate to the Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, Europe, and the United States. It will strive to build a one-stop service platform centered on international cell therapy and health management. It will also actively expand into consumer healthcare sectors such as health and medical aesthetics, anti-aging, and establish an innovative development model driven by a dual focus of “medical care + consumer healthcare.”
